SOX2 and neoplasm: The cohort included patients for whom the endocrine therapy was successful (responders) and the tumour had not returned over a period of 8 years (n = 33 patients) and in which Sox2 was weakly expressed in a low percentage of cells (Allred score ≤2) (Fig 6A).